Population
Individuals with atrial fibrillation
Design
Review
Authors
Loading...
Genotype-based AF subtyping remains hypothesis-generating; leaves open whether it improves outcomes or guides therapy in prospective trials.
Understanding the genetic basis of atrial fibrillation could lead to genotype-guided pharmacogenetic treatment strategies with improved efficacy.
Roberts et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: